Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer

Breast Cancer Research and Treatment

Volumn 121, Issue 1, 2010, Pages 227-231

  Cavalli, Luciane R ^a   Riggins, Rebecca B ^a   Wang, Antai ^a   Clarke, Robert ^a   Haddad, Bassem R ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Disease survival; Interferon regulatory factor 1; IRF1; Tumor suppressor gene

Indexed keywords

ESTROGEN RECEPTOR; INTERFERON REGULATORY FACTOR 1; PROGESTERONE RECEPTOR;

AGE; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE LOCUS; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

AGE FACTORS; BREAST NEOPLASMS; FEMALE; HUMANS; INTERFERON REGULATORY FACTOR-1; LOSS OF HETEROZYGOSITY; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 77951297779     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0509-8     Document Type: Article

References (35)

1. H Nozawa E Oda K Nakao M Ishihara S Ueda T Yokochi K Ogasawara Y Nakatsuru K Hioki S Aizawa T Ishikawa M Katsuki, et al. 1999 Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53 Genes Dev 1-3 1240 1245 10.1101/gad.13.10.1240
2. JL Bos 1989 Ras oncogenes in human cancer: a review Cancer Res 49 4682 4689 1:CAS:528:DyaL1MXltlWksL4%3D 2547513
3. SL Deming SJ Nass RB Dickson BJ Trock 2000 C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance Br J Cancer 83 1688 1695 10.1054/bjoc.2000.1522 1:CAS:528:DC%2BD3MXktFCksQ%3D%3D 11104567 (Pubitemid 32001715)
4. KB Bouker TC Skaar R Riggins DS Harburger DR Fernandez A Zwart A Wang R Clarke 2005 Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis Carcinogenesis 26 1527 1535 10.1093/carcin/bgi113 1:CAS:528: DC%2BD2MXpsValtL8%3D 15878912 (Pubitemid 41244519)
5. PKM Kim M Armstrong Y Liu P Yan B Bucher BS Zuckerbraun A Gambotto TR Billiar JH Yim 2004 IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo Oncogene 23 1125 1135 10.1038/sj.onc.1207023 1:CAS:528:DC%2BD2cXpsFSkug%3D%3D 14762441 (Pubitemid 38269966)
6. Z Gu RY Lee TC Skaar KB Bouker JN Welch J Lu A Liu Y Zhu N Davis F Leonessa N Brunner Y Wang, et al. 2002 Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to faslodex (ICI 182, 780) Cancer Res 62 3428 3437 1:CAS:528:DC%2BD38XkslWqsbo%3D 12067985
7. KB Bouker TC Skaar DR Fernandez KA O'Brien R Clarke 2004 Interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182, 780 (Faslodex, Fulvestrant) Cancer Res 64 4030 4039 10.1158/0008-5472.CAN-03-3602 1:CAS:528:DC%2BD2cXksVKnsLo%3D 15173018 (Pubitemid 38701758)
8. ML Bowie EC Dietze J Delrow GR Bean MM Troch RJ Marjoram VL Seewaldt 2004 Interferon-regulatory factor-1 is critical for tamoxifen-mediated apoptosis in human mammary epithelial cells Oncogene 23 8743 8755 10.1038/sj.onc.1208120 1:CAS:528:DC%2BD2cXpvV2rtb4%3D 15467738 (Pubitemid 39593289)
9. T Tamura M Ishihara MS Lamphier N Tanaka I Oishi S Alzawa T Matsuyama TW Mak S Taki T Taniguchi 1995 An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes Nature 376 596 599 10.1038/376596a0 1:CAS:528:DyaK2MXns1SjtL8%3D 7637809
10. J Sanceau J Hiscott O Delattre J Wietzerbin 2000 IFN-beta induces serine phosphorylation of stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7 Oncogene 19 3372 3383 10.1038/sj.onc.1203670 1:CAS:528:DC%2BD3cXlsFOqtb4%3D 10918594
11. K Suk I Chang YH Kim S Kim JY Kim H Kim MS Lee 2001 Interferon gamma (IFNgamma) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways J Biol Chem 276 13153 13159 10.1074/jbc.M007646200 1:CAS:528:DC%2BD3MXjtFymsLc%3D 11278357
12. N Tanaka M Ishihara MS Lamphier H Nozawa T Matsuyama TW Mak S Aizawa T Tokino M Oren T Taniguchi 1996 Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage Nature 382 816 818 10.1038/382816a0 1:CAS:528:DyaK28XltlWqs7w%3D 8752276 (Pubitemid 26299566)
13. RM Elledge DC Allred 1994 The p53 tumor suppressor gene in breast cancer Breast Cancer Res Treat 32 39 47 10.1007/BF00666204 1:STN:280: DyaK2M7hvFCitg%3D%3D 7819584 (Pubitemid 24322246)
14. M Esteller JM Silva G Dominguez F Bonilla X Matias-Guiu E Lerma E Bussaglia J Prat IC Harkes EA Repasky E Gabrielson M Schutte, et al. 2000 Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors J Natl Cancer Inst 92 564 569 10.1093/jnci/92.7.564 1:CAS:528: DC%2BD3cXivFWqtr8%3D 10749912
15. M Wei TA Grushko J Dignam F Hagos R Nanda L Sveen J Xu J Fackenthal M Tretiakova S Das OI Olopade 2005 BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy Cancer Res 65 10692 10699 10.1158/0008-5472.CAN-05-1277 1:CAS:528: DC%2BD2MXht1Gqu7fI 16322213 (Pubitemid 41713336)
16. CL Willman CE Sever MG Pallavicini H Harada N Tanaka ML Slovak H Yamamoto K Harada TC Meeker AF List T Taniguchi 1993 Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia Science 259 968 971 10.1126/science.8438156 1:CAS:528:DyaK3sXhsVWjt74%3D 8438156
17. S Ogasawara G Tamura C Maesawa Y Suzuki K Ishida N Satoh N Uesugi K Saito R Satodate 1996 Common deleted region on the long arm of chromosome 5 in esophageal carcinoma Gastroenterology 110 52 57 10.1053/gast.1996.v110.pm8536888 1:CAS:528:DyaK28XhtFKitL0%3D 8536888 (Pubitemid 26021604)
18. H Nozawa E Oda S Ueda G Tamura C Maesawa T Muto T Taniguchi N Tanaka 1998 Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer Int J Cancer 77 522 527 10.1002/(SICI)1097- 0215(19980812)77:4<522::AID-IJC8>3.0.CO;2-W 1:CAS:528:DyaK1cXkslKiu7Y%3D 9679752 (Pubitemid 28340897)
19. M Tirkkonen M Tanner R Karhu A Kallioniemi J Isola OP Kallioniemi 1998 Molecular cytogenetics of primary breast cancer by CGH Genes Chromosomes Cancer 21 177 184 10.1002/(SICI)1098-2264(199803)21:3<177::AID-GCC1>3.0.CO;2-X 1:CAS:528:DyaK1cXhslGitbk%3D 9523192 (Pubitemid 28136434)
20. M Tirkkonen O Johannsson BA Agnarsson H Olsson S Ingvarsson R Karhu M Tanner J Isola RB Barkardottir A Borg OP Kallioniemi 1997 Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations Cancer Res 57 1222 1227 1:CAS:528:DyaK2sXit1Kqu7o%3D 9102202
21. HK Johannsdottir G Jonsson G Johannesdottir BA Agnarsson H Eerola A Arason P Heikkila V Egilsson H Olsson OT Johannsson H Nevanlinna A Borg, et al. 2006 Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors Int J Cancer 119 1052 1060 10.1002/ijc.21934 1:CAS:528:DC%2BD28Xns1Cms7Y%3D 16570289 (Pubitemid 44116912)
22. KB Bouker TC Skaar DS Harburger R Riggins DR Fernandez A Zwart R Clarke 2007 The A4396G polymorphism in interferon regulatory factor-1 is frequently expressed in breast cancer Cancer Genet Cytogenet 175 61 64 10.1016/j. cancergencyto.2006.12.008 1:CAS:528:DC%2BD2sXltF2ksro%3D 17498560 (Pubitemid 46695906)
23. H Aziz F Hussain C Sohn R Mediavillo A Saitta A Hussain M Brandys P Homel M Rotman 1999 Early onset of breast carcinoma in African American women with poor prognostic factors Am J Clin Oncol 22 436 440 10.1097/00000421-199910000- 00002 1:STN:280:DyaK1MvkvFelsQ%3D%3D 10521053 (Pubitemid 30263286)
24. HK Weir MJ Thun BF Hankey LA Ries HL Howe PA Wingo A Jemal E Ward RN Anderson BK Edwards 2003 Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control J Natl Cancer Inst 95 1276 1299 12953083
25. VL Shavers LC Harlan JL Stevens 2003 Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35 Cancer 97 134 147 10.1002/cncr.11051 12491515 (Pubitemid 36033873)
26. DR Rhodes J Yu K Shanker N Deshpande R Varambally D Ghosh T Barrette A Pandey AM Chinnaiyan 2004 ONCOMINE: a cancer microarray database and integrated data-mining platform Neoplasia 6 1 6 1:CAS:528:DC%2BD2cXjslSgtrY%3D 15068665
27. Y Wang JG Klijn Y Zhang AM Sieuwerts MP Look F Yang D Talantov M Timmermans ME Meijer-van Gelder J Yu T Jatkoe EM Berns, et al. 2005 Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 365 671 679 1:CAS:528:DC%2BD2MXhsVOitLk%3D 15721472
28. C Desmedt F Piette S Loi Y Wang F Lallemand B Haibe-Kains G Viale M Delorenzi Y Zhang MS d'Assignies J Bergh R Lidereau, et al. 2007 Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series Clin Cancer Res 13 3207 3214 10.1158/1078-0432.CCR-06-2765 1:CAS:528:DC%2BD2sXmtVajur0%3D 17545524 (Pubitemid 46944903)
29. JM Connett L Badri TJ Giordano WC Connett GM Doherty 2005 Interferon regulatory factor 1 (IRF-1) and IRF-2 expression in breast cancer tissue microarrays J Interferon Cytokine Res 25 587 594 10.1089/jir.2005.25.587 1:CAS:528:DC%2BD2MXhtFartbnK 16241857 (Pubitemid 41507814)
30. GM Doherty L Boucher K Sorenson J Lowney 2001 Interferon regulatory factor expression in human breast cancer Ann Surg 233 623 629 10.1097/00000658-200105000-00005 1:STN:280:DC%2BD3MzisFKksQ%3D%3D 11323500 (Pubitemid 32378645)
31. Y Zhu B Singh S Hewitt A Liu B Gomez A Wang R Clarke 2006 Expression patterns among interferon regulatory factor-1, human X-box binding protein-1, nuclear factor kappa B, nucleophosmin, estrogen receptor alpha and progesterone receptor proteins in breast cancer tissue microarrays Int J Oncol 28 67 76 1:CAS:528:DC%2BD28XntlahsQ%3D%3D 16327981
32. SR Payne CJ Kemp 2005 Tumor suppressor genetics Carcinogenesis 26 2031 2045 10.1093/carcin/bgi223 1:CAS:528:DC%2BD2MXht1entL%2FE 16150895 (Pubitemid 41672190)
33. M Santarosa A Ashworth 2004 Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way Biochim Biophys Acta 1654 105 122 1:CAS:528:DC%2BD2cXksVCitr4%3D 15172699
34. MM Book LY Yu-Lee 2001 Sp1 is required for prolactin activation of the interferon regulatory factor-1 gene Mol Cell Endocrinol 184 135 141 10.1016/S0303-7207(01)00593-7 (Pubitemid 32994804)
35. X Li S Leung S Qureshi JE Darnell Jr GR Stark 1996 Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha J Biol Chem 271 5790 5794 10.1074/jbc.271.10. 5790 1:CAS:528:DyaK28XhsFehtLw%3D 8621447 (Pubitemid 26083918)